Player FM ऐप के साथ ऑफ़लाइन जाएं!
Tech-clusion, Gilead, AstraZeneca + Merck + Myriad, DNAnexus
Manage episode 322962481 series 2833924
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Gilead
AstraZeneca + Merck + Myriad
DNAnexus
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
72 एपिसोडस
Manage episode 322962481 series 2833924
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Gilead
AstraZeneca + Merck + Myriad
DNAnexus
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
72 एपिसोडस
모든 에피소드
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।